Literature DB >> 21308712

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Jianjun Liu1, Hyewon Youn, Jun Yang, Ningchao Du, Jihong Liu, Hongwei Liu, Benyi Li.   

Abstract

BACKGROUND: The androgen receptor (AR) is a ligand-dependent transcription factor that mediates androgenic hormone action in cells. We recently demonstrated the involvement of phosphoinositide 3-OH kinase (PI3K) p110beta in AR transactivation and gene expression. In this study, we determined the upstream signals that lead to PI3K/p110beta activation and AR transactivation after androgen stimulation.
METHODS: Human prostate cancer LAPC-4 and 22Rv1 cell lines were used for the experiments. AR transactivation was assessed using an androgen responsive element-driven luciferase (ARE-LUC) assay. Cell proliferation was examined using BrdU incorporation and MTT assays. Target genes were silenced using small interfering RNA (siRNA) approach. Gene expression was evaluated at the mRNA level (real-time RT-PCR) and protein level (Western blot). PI3K kinase activities were measured using immunoprecipitation-based in vitro kinase assay. The AR-DNA-binding activity was determined using chromatin-immunoprecipitation (ChIP) assay.
RESULTS: First, at the cellular plasma membrane, disrupting the integrity of caveolae microdomain with methyl-β-cyclodextrin (M-β-CD) abolished androgen-induced AR transactivation and gene expression. Then, knocking down caveolae structural proteins caveolin-1 or -2 with the gene-specific siRNAs significantly reduced androgen-induced AR transactivation. Next, silencing Gα(s) and Gα(12) genes but not other G-proteins blocked androgen-induced AR transactivation and cell proliferation. Consistently, overexpression of Gα(s) or Gα(12) active mutants enhanced androgen-induced AR transactivation, of which Gα(s) active mutant sensitized the AR to castration-level of androgen (R1881). Most interestingly, knocking down Gα(s) but not Gα(12) subunit significantly suppressed androgen-stimulated PI3K p110beta activation. However, ChIP analysis revealed that both Gα(s) or Gα(12) subunits are involved in androgen-induced AR interaction with the AR target gene PSA promoter region.
CONCLUSION: These data suggest that caveolae-associated G-protein alpha subunits are involved in AR transactivation by modulating the activities of different PI3K isoforms.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21308712      PMCID: PMC3143312          DOI: 10.1002/pros.21345

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  40 in total

Review 1.  The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.

Authors:  Joanne Edwards; John M S Bartlett
Journal:  BJU Int       Date:  2005-06       Impact factor: 5.588

2.  Androgen receptor activation by G(s) signaling in prostate cancer cells.

Authors:  Elizabeth A Kasbohm; Rishu Guo; Charles W Yowell; Gargi Bagchi; Patrick Kelly; Puneeta Arora; Patrick J Casey; Yehia Daaka
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

Review 3.  Requirements for estrogen receptor alpha membrane localization and function.

Authors:  Albert J Evinger; Ellis R Levin
Journal:  Steroids       Date:  2005-03-25       Impact factor: 2.668

4.  Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.

Authors:  Tai-Lung Cha; Lin Qiu; Chun-Te Chen; Yong Wen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

5.  Activation of the human androgen receptor through a protein kinase A signaling pathway.

Authors:  L V Nazareth; N L Weigel
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

6.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.

Authors:  S Li; J Couet; M P Lisanti
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

Review 7.  Androgen receptor in prostate cancer.

Authors:  Cynthia A Heinlein; Chawnshang Chang
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

Review 8.  G proteins in cancer: the prostate cancer paradigm.

Authors:  Yehia Daaka
Journal:  Sci STKE       Date:  2004-01-13

Review 9.  Rapid signalling pathway activation by androgens in epithelial and stromal cells.

Authors:  Gabriella Castoria; Maria Lombardi; Maria Vittoria Barone; Antonio Bilancio; Marina Di Domenico; Antonietta De Falco; Lilian Varricchio; Daniela Bottero; Merlin Nanayakkara; Antimo Migliaccio; Ferdinando Auricchio
Journal:  Steroids       Date:  2004-08       Impact factor: 2.668

10.  Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.

Authors:  Xinbo Liao; J Brantley Thrasher; Jeffery Holzbeierlein; Scott Stanley; Benyi Li
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more
  8 in total

1.  Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.

Authors:  Ruibao Chen; Yunqi Zhao; Yan Huang; Qiuhong Yang; Xing Zeng; Wencong Jiang; Jihong Liu; J Brantley Thrasher; M Laird Forrest; Benyi Li
Journal:  Prostate       Date:  2015-01-25       Impact factor: 4.104

Review 2.  PI-3 kinase p110β: a therapeutic target in advanced prostate cancers.

Authors:  Benyi Li; Aijing Sun; Wencong Jiang; J Brantley Thrasher; Paul Terranova
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

3.  Membrane glucocorticoid receptor activation induces proteomic changes aligning with classical glucocorticoid effects.

Authors:  Sara Vernocchi; Nadia Battello; Stephanie Schmitz; Dominique Revets; Anja M Billing; Jonathan D Turner; Claude P Muller
Journal:  Mol Cell Proteomics       Date:  2013-01-22       Impact factor: 5.911

4.  Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

Authors:  Melyssa R Bratton; James W Antoon; Bich N Duong; Daniel E Frigo; Syreeta Tilghman; Bridgette M Collins-Burow; Steven Elliott; Yan Tang; Lilia I Melnik; Ling Lai; Jawed Alam; Barbara S Beckman; Steven M Hill; Brian G Rowan; John A McLachlan; Matthew E Burow
Journal:  J Endocrinol       Date:  2012-05-04       Impact factor: 4.286

Review 5.  Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.

Authors:  Franck Mauvais-Jarvis; Carol A Lange; Ellis R Levin
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

6.  MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Wei Zhou; Sujoy Ghosh; Patrick J Casey
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

7.  Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.

Authors:  Ji Hee Ha; Rohini Gomathinayagam; Mingda Yan; Muralidharan Jayaraman; Rajagopal Ramesh; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2015-07

8.  Gαs protein expression is an independent predictor of recurrence in prostate cancer.

Authors:  Lijuan Wang; Guihua Jin; Chenchen He; Xijing Guo; Xia Zhou; Meng Li; Xia Ying; Le Wang; Huili Wu; Qing Zhu
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.